ASCE+ IRLV INTIMATE CARE FOR WOMEN (500MG + 5ML)

Lyophilized powder formulation engineered with ExoSCRT® Exosome Complex. Manufactured in South Korea under ISO 22716:2007 stringent standards for premium gynecological cosmetics. Validated for vaginal mucosa application.

Proprietary Technology & Specifications

US Patent Certification: US 10,800,765 B2.
Delivery System: 40-100nm nanoparticle formulation yielding 2.5x higher mucosal bioavailability versus standard topical emulsions.
Purification: 11-step dual-filtration protocol eliminates 99.3% of cellular impurities.
Packaging Integrity: Sterile Twin-Vial System utilizing medical-grade PP/PETG. Secured with NFC-enabled anti-counterfeit cryptographic seal.

Clinical Application Protocol

Medical Disclaimer: Contains bioactive exosome components. Efficacy parameters are based on 2023 multicenter in-vivo trials; individual physiological responses may deviate. This product is categorized as a gynecological cosmetic and is not evaluated by the FDA to diagnose, treat, cure, or prevent any medical condition. Immunocompromised individuals or pregnant patients must obtain gynecological clearance prior to protocol initiation.